Ohemo Life patents expiration
1. Morphabond Er patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US10314788 | OHEMO LIFE | Pharmaceutical compositions configured to deter dosage form splitting |
Aug, 2028
(4 years from now) | |
| US7955619 | OHEMO LIFE | Abuse resistant drugs, method of use and method of making |
Aug, 2028
(4 years from now) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| M(M-189) | Oct 02, 2018 |
Drugs and Companies using MORPHINE SULFATE ingredient
Market Authorisation Date: 02 October, 2015
Treatment: NA
Dosage: TABLET, EXTENDED RELEASE;ORAL
How can I launch a generic of MORPHABOND ER before it's drug patent expiration?
More Information on Dosage
MORPHABOND ER family patents
